To avoid this, Chambers et al. genetically modified NK cells by introducing an anti-CD37 scFv CAR, enabling them to effectively eliminate lung cancer cells with high CD37 expression even under hypoxic conditions [108]. Here, CD37 is linked to lung cancer.